AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own EPAM today, you need to believe that its push into AI-native services can offset slower discretionary IT spending and margin pressure. The latest Q1 beat, modest 2026 growth guidance and completion of a US$547.49 million buyback do not materially change the key near term catalyst, which is converting its AI pipeline into scaled, recurring work. The main risk remains weaker client budgets that could mute the impact of EPAM’s expanding AI offering.
The most relevant recent development is EPAM’s deepened multi year partnership with Anthropic, including plans for over 10,000 Claude certified architects and production grade AI for platforms like ServiceNow. This ties directly into the AI adoption catalyst, giving EPAM a clearer story around applied AI delivery at scale just as clients are reassessing spend and vendor choices after the updated 2026 outlook.
Yet even as EPAM leans into AI, investors should be aware that weaker discretionary client budgets could still...
Read the full narrative on EPAM Systems (it's free!)
EPAM Systems' narrative projects $6.7 billion revenue and $551.8 million earnings by 2029. This requires 6.9% yearly revenue growth and about a $174 million earnings increase from $377.7 million today.
Uncover how EPAM Systems' forecasts yield a $187.24 fair value, a 89% upside to its current price.
Some of the most optimistic analysts were assuming roughly 9 percent annual revenue growth and earnings above US$640 million by 2029, so compared with the more cautious consensus and today’s softer guidance, their AI fueled margin expansion story looks far more ambitious and may need to be revisited in light of EPAM’s latest update.
Explore 6 other fair value estimates on EPAM Systems - why the stock might be worth over 2x more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com